Investegate |Akari Therapeutics Plc Announcements | Akari Therapeutics Plc: Akari Therapeutics Announces Pre-Clinical Development Progress Toward Potential IND on Long-Acting PAS-Nomacopan for Geographic Atrophy (GA)

Investegate announcements from Akari Therapeutics Plc, Akari Therapeutics Announces Pre-Clinical Development Progress Toward Potential IND on Long-Acting PAS-Nomacopan for Geographic Atrophy (GA)

Related Keywords

London ,City Of ,United Kingdom ,Mike Moyer ,Eliza Schleifstein ,Elias Reichel ,Rachelle Jacques ,Exchange Commission ,Clinical Development Progress Toward Potential ,Tufts University School Of Medicine ,Drug Administration ,Department Of Ophthalmology ,Nasdaq ,Akari Therapeutics Plc Nasdaq ,Geographic Atrophy ,Investigational New Drug ,Vice Chair ,Tufts University School ,Approval Pending ,Pegcetacoplan Shows Mixed Results ,Treating Geographic Atrophy ,Assess Life Impact ,Intravitreal Injections ,Prog Mol Biol Transl ,Orphan Drug ,Fast Track ,Rare Pediatric Disease ,Private Securities Litigation Reform Act ,Annual Report ,Investegate Announcements ,Investegate Company Announcements ,Akari Therapeutics Plc ,Lobenewswire ,Lobenewswire And Globenewswire ,Nw ,